Newsby HottubFor agents

Barre Montpelier Times Argus

Perioperative IMFINZI® (durvalumab) approved in the US in novel regimen with neoadjuvant enfortumab vedotin-ejfv for patients with muscle-invasive bladder cancer

WILMINGTON, Del.--(BUSINESS WIRE)--Nov 13, 2026--

Add to CRM by Hottub

Everyone in this article who could become a relationship. Add opens CRM by Hottub's form, filled in; nothing is saved until you press Add there.

  • Barre Montpelier Times ArgusOutlet
    Add